Covagen
	Operator of a biopharmaceutical company focused on therapies for inflammatory diseases and cancer. The company provides a proprietary platform that genetically fuses Fynomer binding proteins to antibodies, resulting in therapeutics with novel modes of action. The company’s first clinical drug candidate is designed for treatment of rheumatoid arthritis, psoriatic arthritis and other inflammatory diseases.
	['', 'inflammation binder', ' ', 'protein therapy', ' ', 'clinical drug', '']
Link Medicine
	Operator of a privately held biotechnology company advancing novel approaches for the treatment of neurodegenerative diseases. The company is developing treatments for multiple diseases, including Alzheimer’s, Parkinson’s, Huntington’s, and Amyotrophic Lateral Sclerosis (ALS). It targets a common feature of the disorders - the buildup in nerve cells of incorrectly folded, aggregated and ultimately neurotoxic proteins.
	['', 'neurodegenerative disease', ' Alzheimer’s Parkinson’s, Huntington’s ', 'Amyotrophic Lateral Sclerosis', ' ALS']
Radiant Medical
	Developer of endovascular temperature therapy products. The company offers its products to advance the treatment of patients with acute ischemic or inflammatory medical conditions, such as heart attack, radiocontrast nephropathy, stroke, and cardiac arrest.
	['', 'endovascular temperature therapy', ' ', 'medical care product', ' ', 'acute ischemic treatment', '']
Intracellular Therapies
	Developer of drugs for the treatment of diseases and disorders of the Central Nervous System (CNS). The company develops compounds to treat neuropsychiatric and neurological diseases. It also develops a state of the art technology platform for generating a unique molecular signature for drug compounds.
	['', 'neuropsychiatric disease treatment', ' ', 'neurological disease treatment', ' ', 'drug compound', ' ', 'drug development', '']
StormBio
	Developer of therapy for influenza and other inflammatory diseases. The company is developing a new class of therapeutics designed to target only an over-reaction of the inflammatory process, without shutting down the body\'s immune response.
	['', 'influenza', ' ', 'inflammation treatment', ' ', 'pandemic', ' ', 'biopharm', '']
Centaur Pharmaceuticals
	Developer of novel class of small molecule pharmaceutical compounds for the treatment of neurodegenerative and inflammatory diseases. The company develops such compounds to treat inflammatory diseases such as acute stroke, dementia, rheumatoid arthritis, myocardial ischemia and Parkinson’s disease.
	['', 'molecule pharmaceutical compound', ' ', 'pharmaceutical products', '']
